Stocksigma LogoStocksigma Logo

Rossari Biotech Posts Q2 FY27 Results; Approves KSA Greenfield Land Lease

Rossari Biotech reported Q2 FY27 consolidated revenue of ₹6,975.60 mn, up 19.0% YoY, with net profit rising 5.5% YoY to ₹389.07 mn

Rossari Biotech Posts Q2 FY27 Results; Approves KSA Greenfield Land Lease

Rossari Biotech Ltd · Others (Uncategorized) · 18 Oct 2026, 1:04 am

Rossari Biotech Posts Q2 FY27 Results; Approves KSA Greenfield Land Lease Rossari Biotech reported Q2 FY27 consolidated revenue of ₹6,975.60 mn, up 19.0% YoY, with net profit rising 5.5% YoY to ₹389.07 mn. Diluted EPS stood at ₹7.02 versus ₹6.65 in Q2 FY26. For H1 FY27, revenue reached ₹13,947.60 mn and PAT increased to ₹740.02 mn. In a key strategic move, the board approved the leasing of land by wholly owned subsidiary Rossari International Company Limited to establish a greenfield manufacturing facility in Saudi Arabia, with project details and capex pending finalization.

Original exchange filing (PDF)

More announcements from Rossari Biotech Ltd

All Rossari Biotech Ltd announcements